JESSICA FOSTER: Open Payments
NPI 1457515363 · KENNESAW, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$708 in 36 payments from 14 companies in 2025. Trend: 2023 $260 · 2024 $400 · 2025 $708
Food & beverage: $663Education: $45
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $119 |
| Novo Nordisk Inc | 6 | $106 |
| ABBVIE INC. | 4 | $93 |
| Abbott Laboratories | 4 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| Dynavax Technologies Corporation | 2 | $49 |
| Astellas Pharma US Inc | 2 | $47 |
| IBSA Pharma Inc. | 2 | $41 |
| PFIZER INC. | 2 | $30 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: FREESTYLE LIBRE 3, JARDIANCE, Ozempic, MOUNJARO, QULIPTA, Heplisav-B, Veozah, UBRELVY.
Industry payments across GA — which companies pay providers there.
